Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8cyclopia sequence 6Prostatic Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Neoplasms, Plasma Cell 2Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Hematologic Diseases 2Head and Neck Neoplasms 2Fatigue 2Warts 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Recurrence 1Prostatic Intraepithelial Neoplasia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Papilloma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neuromyelitis Optica 1Myelitis, Transverse 1Myelitis 1Melanoma 1

Interventions

Doxorubicin 5Filgrastim 4Zidovudine 3Vincristine 3Etoposide 3Valganciclovir 2Thalidomide 2Rituximab 2Mitoxantrone 2Interferon alpha-2 2Cyclophosphamide 2Bleomycin 2ziconotide 1vesnarinone 1tocilizumab 1tin etiopurpurin 1interferon gamma-1b 1human papillomavirus vaccine, L1 type 16, 18 1Vinblastine 1Tumor Necrosis Factor-alpha 1Sugars 1Semaxinib 1Ro 24-7429 1Ritonavir 1Prednisone 1Paclitaxel 1Nivolumab 1Mitoguazone 1Methotrexate 1Medical Marijuana 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Acquired Immunodeficiency Syndrome × Sugars × Clear all
NCT00454181 2011-09-16

Treatment of Oral Warts in HIV+ Patients

Ainos, Inc. (f/k/a Amarillo Biosciences Inc.

Phase 2 Completed
59 enrolled 13 charts

Acquired Immunodeficiency Syndrome, Papilloma, Warts, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡